Also known as: U926, LYME DISEASE, BORRELIA, TICK-BORNE LYME
Test Contains (LOINC): Borrelia burgdorferi (32667-8), Borrelia mayonii (no LOINC), Borrelia miyamotoi (no LOINC), Specimen (no LOINC)
Sample Type: Whole Blood, Plasma or Serum
Preferred Container: EDTA (Lavender Top) Tube or Serum Separator Tube (SST)
Minimal Sample Volume: 1.0 mL (does not allow for repeat testing)
Whole Blood: Refrigerate specimen after collection. Transport refrigerated. Plasma or Serum: Collect specimen per tube manufacturer’s instructions. Centrifuge sample and separate serum or plasma from cells ASAP.
Client Transport Temperature: Refrigerated
Specimen Stability: Ambient: 3 Days; Refrigerated: 2 Weeks; Frozen: 1 Month
Unsuitable Specimen: Heparinized specimens. Synovial fluid. Tissue. CSF
Frequency: Monday, Wednesday, Friday
Expected Turn Around: 2 – 5 Days
Responsible Dept: Reference Lab
Methodology: Real-Time Polymerase Chain Reaction
Testing for Lyme disease (Borrelia spp.) by PCR in blood specimens should be performed in conjunction with recommended serologic tests.
Ordering Recommendation: For detection and differentiation of causative agents of Lyme disease in peripheral blood during the acute phase of illness.
Compliance Statement: This test was developed and its performance characteristics determined by Sonic Reference Laboratory (SRL). It has not been cleared or approved by the U.S. Food and Drug Administration (FDA). The FDA has determined that such clearance or approval is not necessary. This test is used for clinical purposes and should not be regarded as investigational or for research. SRL is qualified to perform high complexity testing under the Clinical Laboratory Improvement Amendments (CLIA).
REPLACES U700- LYME DNA